HEXAL launches Dimethyl fumarate HEXAL® a generic drug for Tecfidera®, in Germany, offering an economically efficient treatment option for the care of adult patients with multiple sclerosis*
- Dimethyl fumarate HEXAL® is bioequivalent to the originator product 1,2,3
- Additional 196 pack size reduces co-payment burden for patients
Basel, June 10, 2022 — Sandoz expands its portfolio and today announces the launch of the generic drug Dimethyl fumarate HEXAL®, which is approved for the treatment of adults with relapsing remitting multiple sclerosis (RRMS) 1, in Germany.
“We are proud to introduce a generic drug for German patients for the treatment of …